NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Males aged 18 years with prostate cancer treated with abiraterone (arm 1) or not treated with abiraterone (arm 2). Patients with abiraterone treatment will take abiraterone 1000 mg per day.
1 total trials1 recruiting
Filter these 1 trials by phase, country, sponsor and more.